APA (7th ed.) Citation

Bouwhuis, M. G., Gast, A., Figl, A., Eggermont, A. M. M., Hemminki, K., Schadendorf, D., & Kumar, R. (2010). Polymorphisms in the CD28/CTLA4/ICOS genes: Role in malignant melanoma susceptibility and prognosis? Cancer immunology immunotherapy, 59(2), . https://doi.org/10.1007/s00262-009-0751-2

Chicago Style (17th ed.) Citation

Bouwhuis, Marna G., Andreas Gast, Adina Figl, Alexander M. M. Eggermont, Kari Hemminki, Dirk Schadendorf, and Rajiv Kumar. "Polymorphisms in the CD28/CTLA4/ICOS Genes: Role in Malignant Melanoma Susceptibility and Prognosis?" Cancer Immunology Immunotherapy 59, no. 2 (2010). https://doi.org/10.1007/s00262-009-0751-2.

MLA (9th ed.) Citation

Bouwhuis, Marna G., et al. "Polymorphisms in the CD28/CTLA4/ICOS Genes: Role in Malignant Melanoma Susceptibility and Prognosis?" Cancer Immunology Immunotherapy, vol. 59, no. 2, 2010, https://doi.org/10.1007/s00262-009-0751-2.